Comerica Bank
XERS icon

Comerica Bank’s Xeris Biopharma Holdings XERS Stock Holding History

Comerica Bank’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-308
Closed -$2.51K – 3826
2025
Q3 		$2.51K Buy
+308
New +$2.05K ﹤0.01% 3502
2024
Q4 		– Sell
-611
Closed -$1.74K – 3756
2024
Q3 		$1.74K Buy
+611
New +$1.57K ﹤0.01% 3519
2024
Q2 		– Sell
-417
Closed -$922 – 3821
2024
Q1 		$922 Buy
+417
New +$1.08K ﹤0.01% 3627

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Comerica Bank's XERS Position: Q4 2025 in Review

Comerica Bank sold out of Xeris Biopharma Holdings (XERS) in Q4 2025, closing a stake of 308 shares — an estimated $2.51K sold.

Comerica Bank first reported a position in XERS in Q1 2024 and held it in 3 quarters. The position peaked at $2.51K in Q3 2025. 225 funds tracked by Wall St. Rank hold XERS as of Q4 2025.

  • Comerica Bank reported no remaining Xeris Biopharma Holdings position as of Q4 2025 after selling out during the quarter.
  • Comerica Bank sold 308 Xeris Biopharma Holdings shares in Q4 2025, an estimated $2.51K.
  • Comerica Bank first reported a position in Xeris Biopharma Holdings in Q1 2024 and held it in 3 quarters.
  • Comerica Bank's Xeris Biopharma Holdings position peaked at $2.51K in Q3 2025.
  • 225 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.